The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.
The pathogenic form of the cyclooxygenase (COX) enzyme, COX-2, is also constitutively present in the spinal cord and has been implicated in chronic pain states in rat and man. A number of COX-2 inhibitors, including celecoxib and rofecoxib, are already used in man for the treatment of inflammatory p...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2005
|
| _version_ | 1797072205133119488 |
|---|---|
| author | Bingham, S Beswick, P Bountra, C Brown, T Campbell, I Chessell, I Clayton, N Collins, S Davey, P Goodland, H Gray, N Haslam, C Hatcher, J Hunter, A Lucas, F Murkitt, G Naylor, A Pickup, E Sargent, B Summerfield, S Stevens, A Stratton, S Wiseman, J |
| author_facet | Bingham, S Beswick, P Bountra, C Brown, T Campbell, I Chessell, I Clayton, N Collins, S Davey, P Goodland, H Gray, N Haslam, C Hatcher, J Hunter, A Lucas, F Murkitt, G Naylor, A Pickup, E Sargent, B Summerfield, S Stevens, A Stratton, S Wiseman, J |
| author_sort | Bingham, S |
| collection | OXFORD |
| description | The pathogenic form of the cyclooxygenase (COX) enzyme, COX-2, is also constitutively present in the spinal cord and has been implicated in chronic pain states in rat and man. A number of COX-2 inhibitors, including celecoxib and rofecoxib, are already used in man for the treatment of inflammatory pain. Preclinically, the dual-acting COX-2 inhibitor, GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine, where X denotes the free base], is as effective as rofecoxib and celecoxib in the rat established Freund's Complete Adjuvant model with an ED(50) of 1.5 mg/kg p.o. compared with 1.0 mg/kg p.o. for rofecoxib and 6.6 mg/kg p.o. for celecoxib. However, in contrast to celecoxib (5 mg/kg p.o. b.i.d.) and rofecoxib (5 mg/kg p.o. b.i.d.), which were without significant effect, GW406381X (5 mg/kg p.o. b.i.d.) fully reversed mechanical allodynia in the chronic constriction injury model and reversed thermal hyperalgesia in the mouse partial ligation model, both models of neuropathic pain. GW406381X, was also effective in a rat model of capsaicin-induced central sensitization, when given intrathecally (ED(50) = 0.07 mug) and after chronic but not acute oral dosing. Celecoxib and rofecoxib had no effect in this model. Several hypotheses have been proposed to try to explain these differences in efficacy, including central nervous system penetration, enzyme kinetics, and potency. The novel finding of effectiveness of GW406381X in these models of neuropathic pain/central sensitization, in addition to activity in inflammatory pain models and together with its central efficacy, suggests dual activity of GW406381X compared with celecoxib and rofecoxib, which may translate into greater efficacy in a broader spectrum of pain states in the clinic. |
| first_indexed | 2024-03-06T23:04:21Z |
| format | Journal article |
| id | oxford-uuid:6344aff1-8fc3-4b76-9cf8-8cb5dd103515 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:04:21Z |
| publishDate | 2005 |
| record_format | dspace |
| spelling | oxford-uuid:6344aff1-8fc3-4b76-9cf8-8cb5dd1035152022-03-26T18:11:54ZThe cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6344aff1-8fc3-4b76-9cf8-8cb5dd103515EnglishSymplectic Elements at Oxford2005Bingham, SBeswick, PBountra, CBrown, TCampbell, IChessell, IClayton, NCollins, SDavey, PGoodland, HGray, NHaslam, CHatcher, JHunter, ALucas, FMurkitt, GNaylor, APickup, ESargent, BSummerfield, SStevens, AStratton, SWiseman, JThe pathogenic form of the cyclooxygenase (COX) enzyme, COX-2, is also constitutively present in the spinal cord and has been implicated in chronic pain states in rat and man. A number of COX-2 inhibitors, including celecoxib and rofecoxib, are already used in man for the treatment of inflammatory pain. Preclinically, the dual-acting COX-2 inhibitor, GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine, where X denotes the free base], is as effective as rofecoxib and celecoxib in the rat established Freund's Complete Adjuvant model with an ED(50) of 1.5 mg/kg p.o. compared with 1.0 mg/kg p.o. for rofecoxib and 6.6 mg/kg p.o. for celecoxib. However, in contrast to celecoxib (5 mg/kg p.o. b.i.d.) and rofecoxib (5 mg/kg p.o. b.i.d.), which were without significant effect, GW406381X (5 mg/kg p.o. b.i.d.) fully reversed mechanical allodynia in the chronic constriction injury model and reversed thermal hyperalgesia in the mouse partial ligation model, both models of neuropathic pain. GW406381X, was also effective in a rat model of capsaicin-induced central sensitization, when given intrathecally (ED(50) = 0.07 mug) and after chronic but not acute oral dosing. Celecoxib and rofecoxib had no effect in this model. Several hypotheses have been proposed to try to explain these differences in efficacy, including central nervous system penetration, enzyme kinetics, and potency. The novel finding of effectiveness of GW406381X in these models of neuropathic pain/central sensitization, in addition to activity in inflammatory pain models and together with its central efficacy, suggests dual activity of GW406381X compared with celecoxib and rofecoxib, which may translate into greater efficacy in a broader spectrum of pain states in the clinic. |
| spellingShingle | Bingham, S Beswick, P Bountra, C Brown, T Campbell, I Chessell, I Clayton, N Collins, S Davey, P Goodland, H Gray, N Haslam, C Hatcher, J Hunter, A Lucas, F Murkitt, G Naylor, A Pickup, E Sargent, B Summerfield, S Stevens, A Stratton, S Wiseman, J The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. |
| title | The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. |
| title_full | The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. |
| title_fullStr | The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. |
| title_full_unstemmed | The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. |
| title_short | The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. |
| title_sort | cyclooxygenase 2 inhibitor gw406381x 2 4 ethoxyphenyl 3 4 methylsulfonyl phenyl pyrazolo 1 5 b pyridazine is effective in animal models of neuropathic pain and central sensitization |
| work_keys_str_mv | AT binghams thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT beswickp thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT bountrac thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT brownt thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT campbelli thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT chesselli thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT claytonn thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT collinss thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT daveyp thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT goodlandh thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT grayn thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT haslamc thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT hatcherj thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT huntera thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT lucasf thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT murkittg thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT naylora thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT pickupe thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT sargentb thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT summerfields thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT stevensa thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT strattons thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT wisemanj thecyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT binghams cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT beswickp cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT bountrac cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT brownt cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT campbelli cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT chesselli cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT claytonn cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT collinss cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT daveyp cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT goodlandh cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT grayn cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT haslamc cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT hatcherj cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT huntera cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT lucasf cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT murkittg cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT naylora cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT pickupe cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT sargentb cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT summerfields cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT stevensa cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT strattons cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization AT wisemanj cyclooxygenase2inhibitorgw406381x24ethoxyphenyl34methylsulfonylphenylpyrazolo15bpyridazineiseffectiveinanimalmodelsofneuropathicpainandcentralsensitization |